2006/01/01 216. zenbakia

eu es fr en cat gl

• Itzulpen automatikoa
  • Español
  • Français
  • English
  • Català
  • Galego
  • Jatorrizkora itzuli

Elia Elhuyar

×

Aparecerá un contenido traducido automáticamente. ¿Deseas continuar?

Si No

Elia Elhuyar

×

Un contenu traduit automatiquement apparaîtra. Voulez-vous continuer?

Oui No

Elia Elhuyar

×

An automatically translated content item will be displayed. Do you want to continue?

Yes No

Elia Elhuyar

×

Apareixerà un contingut traduït automàticament. Vols continuar?

Si No

Elia Elhuyar

×

Aparecerá un contido traducido automaticamente. ¿Desexas continuar?

Se No

• Medikuntza

Vaccination of follicular lymphoma

• Zabaldu:
• Twitter
• Facebook
• Emaila

A team of researchers from the University Clinic of Navarra and the Center for Applied Medical Research has proven the efficacy and clinical usefulness of a vaccine against follicular lymphoma.

Follicular lymphoma is a type of blood cancer, a tumor of the lymphatic system. The cells contain a superficial protein, immunoglobulin, and the vaccine comes from this protein, which aims to affect the patient's immune system.

The vaccine is given subcutaneously and in particular is complementary to chemotherapy. The vaccine has also been used as a first treatment, but the results have not been good.